Latest Novartis AG Stories
ReportsnReports.com adds Hepatitis B Global Clinical Trials Review H2 2014 to its store.
ReportsnReports.com adds Hepatitis C Global Clinical Trials Review H2 2014 to its store.
AUSTIN, Texas, Nov. 4, 2014 /PRNewswire/ -- XBiotech announced today that Dr. Daniel Vasella has joined the Company as a member of the Board of Directors. Dr.
-- LANTERN study met primary endpoint demonstrating non-inferiority of Ultibro® Breezhaler® 110/50 mcg vs Advair* Diskus* (SFC) 50/500 mcg followed by statistically
-- LCZ696 mortality benefit exceeded what was achieved with enalapril, an ACE-inhibitor, when replacing enalapril combined with current treatment
DUBLIN, Ireland, August 21, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/3zh3q8/global_hormone) has announced the addition of
DUBLIN, July 31, 2014 /PRNewswire/ -- Research and Markets has announced the addition
- A trick or prank.